[{"AccountsPayableCurrent_0_Q3_USD":3731000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":254000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":85547000.0,"OtherNoncashIncomeExpense_3_Q3_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2275000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3_Q3_USD":5000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q3_USD":9000.0,"OtherAssetsNoncurrent_0_Q3_USD":1457000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":200000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":-100000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q3_USD":100000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1461000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3649000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1100000.0,"OperatingIncomeLoss_3_Q3_USD":-50647000.0,"OperatingIncomeLoss_1_Q3_USD":-14134000.0,"OperatingExpenses_3_Q3_USD":53396000.0,"OperatingExpenses_1_Q3_USD":14342000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"NonoperatingIncomeExpense_3_Q3_USD":180000.0,"NonoperatingIncomeExpense_1_Q3_USD":91000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-50467000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":-14043000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-50467000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-14043000.0,"NetIncomeLoss_3_Q3_USD":-50467000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":430000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":113238000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":16960000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":24600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":8487485.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":11183578.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_3_Q3_USD":0.0,"UnrealizedGainLossOnInvestments_3_Q3_USD":-5000.0,"UnrealizedGainLossOnInvestments_1_Q3_USD":9400.0,"UnbilledReceivablesCurrent_0_Q3_USD":479000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":24000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q3_USD":0.0,"StockholdersEquity_0_Q3_USD":204591000.0,"ShortTermInvestments_0_Q3_USD":74937000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":3367418.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":2969138.0,"ShareBasedCompensation_3_Q3_USD":10974000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":2749000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":208000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-329354000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":34492000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":8121000.0,"RepaymentsOfNotesPayable_3_Q3_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":347000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":2115000.0,"ProceedsFromWarrantExercises_3_Q3_USD":939000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":331000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":77000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":67042000.0,"ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans_3_Q3_USD":12000.0,"ProceedsFromNotesPayable_3_Q3_USD":0.0,"NetIncomeLoss_1_Q3_USD":-14043000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":11183578.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-38046000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":125105000.0,"CommonStockSharesOutstanding_0_Q3_shares":19376634.0,"CommonStockSharesIssued_0_Q3_shares":19376634.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CommitmentsAndContingencies_0_Q3_USD":null,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":441545.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q3_USD":15.94,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":92978000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":138875000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":213800000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":23000.0,"AssetsCurrent_0_Q3_USD":217940000.0,"CommonStockValue_0_Q3_USD":194000.0,"Assets_0_Q3_USD":221205000.0,"AmortizationOfFinancingCosts_3_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":10974000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3982000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q3_USD":6149000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3982000.0,"AdditionalPaidInCapital_0_Q3_USD":372291000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-3000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":1768000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1451000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":10320000.0,"AccretionExpense_3_Q3_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-715000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":26774099.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-14034000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-50462000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":288000.0,"LiabilitiesCurrent_0_Q3_USD":14339000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":221205000.0,"Liabilities_0_Q3_USD":16614000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1600000.0,"InterestPaidNet_3_Q3_USD":0.0,"InterestAndDebtExpense_3_Q3_USD":0.0,"InterestAndDebtExpense_1_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2277000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":707000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-246000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3061000.0,"IncomeTaxExaminationPenaltiesAndInterestExpense_3_Q3_USD":0.0,"IncomeTaxExaminationPenaltiesAndInterestExpense_1_Q3_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q3_USD":0.0,"GeneralAndAdministrativeExpense_3_Q3_USD":18904000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6221000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-75000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":42800000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2349000.0,"EarningsPerShareDiluted_3_Q3_USD":-5.95,"EarningsPerShareDiluted_1_Q3_USD":-1.25,"EarningsPerShareBasic_3_Q3_USD":-5.95,"EarningsPerShareBasic_1_Q3_USD":-1.25,"DepreciationDepletionAndAmortization_3_Q3_USD":88000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":30000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_3_Q3_USD":1065000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":5918000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":8487485.0,"Ticker":"VRDN","CIK":"1590750","name":"VIRIDIAN THERAPEUTICS, INC.DE","OfficialName":"Viridian Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"445189274.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]